Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same author

Management and Prevention of Histotripsy-Induced Acute Bland Portal Vein Thrombosis in Histotripsy Treated Liver Tumors.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Histotripsy-Induced Acute Kidney Injury Following Liver Tumor Treatment: A Preliminary Report of 9 Cases.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Pictorial review of the LI-RADS radiation-based treatment response algorithm v2024.

Abdominal radiology (New York)·2026
Same author

Histotripsy dose impacts tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinoma.

Scientific reports·2026
Same author

How I Do It: Systemic Therapies for Primary Liver Cancers.

Radiology·2026
Same journal

Correction: Standardizing computed tomographic assessment of the mesopancreas in pancreatic cancer patients.

Abdominal radiology (New York)·2026
Same journal

Seeing the invisible: practical strategies to maximize the clinical impact of photon-counting CT in abdominal imaging.

Abdominal radiology (New York)·2026
Same journal

Interventional radiology in the management of complications after pancreatic surgery: a single-center experience.

Abdominal radiology (New York)·2026
Same journal

Growth without dilution: impact, integrity, and the next phase of abdominal radiology.

Abdominal radiology (New York)·2026
Same journal

Pearls and pitfalls in the imaging of blunt bowel and mesenteric injury.

Abdominal radiology (New York)·2026
Same journal

Location- and ADC-based stratification of transition zone PI-RADS 3 lesions to optimize biopsy indication.

Abdominal radiology (New York)·2026
See all related articles

Related Experiment Video

Updated: Nov 22, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.7K

HCC Treatment Response DFP report

Mishal Mendiratta-Lala1

  • 1Department of Radiology, University of Michigan, Ann Arbor, USA. mmendira@med.umich.edu.

Abdominal Radiology (New York)
|January 8, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

853
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.2K

Related Experiment Videos

Last Updated: Nov 22, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.7K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

853
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.2K